NCT00709735View on ClinicalTrials.gov

A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

August 31, 2010

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Propranolol

0.67 mg/kg short-acting propranolol combined with 1 mg/kg long-acting propranolol

DRUG

Placebo

Placebo (matching propranolol) short-acting and long-acting capsules

Trial Locations (3)

01730

VA Medical Center, Bedford

02108

Massachusetts General Hospital, Boston

03104

VA Medical Center, Manchester

All Listed Sponsors
collaborator

VA Office of Research and Development

FED

lead

Massachusetts General Hospital

OTHER

NCT00709735 - A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol | Biotech Hunter | Biotech Hunter